Vanda Pharmaceuticals (VNDA) Other Gross PP&E Adjustments (2011 - 2026)
Vanda Pharmaceuticals recorded quarterly Other Gross PP&E Adjustments of -$13.2 million in Q1 2026, down 276.11% quarter-over-quarter from $7.5 million in Q4 2025, and down 26.59% year-over-year from -$18.0 million in Q1 2025.
Vanda Pharmaceuticals' Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at -$13.2 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 26.59% year-over-year to -$13.2 million; the TTM figure through Mar 2026 stood at -$13.2 million (down 26.59% YoY), while the FY2025 annual figure was $7.5 million, down 7.11% from the prior year.
- Other Gross PP&E Adjustments came in at -$13.2 million for Q1 2026 at Vanda Pharmaceuticals, down from $7.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $8.1 million in Q4 2024 to a low of -$13.2 million in Q1 2026.
- A 5-year average of -$5.6 million and a median of -$8.5 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments soared 42.7% in 2022 and decreased 29.92% in 2024, its largest moves.
- Vanda Pharmaceuticals' Other Gross PP&E Adjustments stood at $4.6 million in 2022, then surged by 33.17% to $6.1 million in 2023, then soared by 32.41% to $8.1 million in 2024, then fell by 7.11% to $7.5 million in 2025, then tumbled by 276.11% to -$13.2 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$13.2 million, $7.5 million, and -$6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -13.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.25 Mn |
| Mar 31, 2026 | -13.25 Mn |
| Dec 31, 2025 | 7.52 Mn |
| Dec 31, 2025 | 7.52 Mn |
| Sep 30, 2025 | -6.12 Mn |
| Sep 30, 2025 | -6.12 Mn |
| Jun 30, 2025 | -8.31 Mn |
| Jun 30, 2025 | -8.31 Mn |
| Mar 31, 2025 | -10.46 Mn |
| Mar 31, 2025 | -10.46 Mn |
| Dec 31, 2024 | 8.10 Mn |
| Dec 31, 2024 | 8.10 Mn |
| Sep 30, 2024 | -7.77 Mn |
| Sep 30, 2024 | -7.77 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Mar 31, 2024 | -12.00 Mn |
| Mar 31, 2024 | -12.00 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | -7.79 Mn |
| Sep 30, 2023 | -7.79 Mn |
| Jun 30, 2023 | -8.54 Mn |
| Jun 30, 2023 | -8.54 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Sep 30, 2022 | -8.64 Mn |
| Sep 30, 2022 | -8.64 Mn |
| Jun 30, 2022 | -9.36 Mn |
| Jun 30, 2022 | -9.36 Mn |
| Mar 31, 2022 | -10.08 Mn |
| Mar 31, 2022 | -10.08 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | -9.95 Mn |
| Sep 30, 2021 | -9.95 Mn |
| Jun 30, 2021 | -10.64 Mn |
| Jun 30, 2021 | -10.64 Mn |
| Mar 31, 2021 | -11.30 Mn |
| Mar 31, 2021 | -11.30 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | -10.68 Mn |
| Sep 30, 2020 | -10.68 Mn |
| Jun 30, 2020 | -11.34 Mn |
| Jun 30, 2020 | -11.34 Mn |
| Mar 31, 2020 | -11.98 Mn |
| Mar 31, 2020 | -11.98 Mn |
| Dec 31, 2019 | -704,000.00 |
| Dec 31, 2019 | -704,000.00 |
| Sep 30, 2019 | -11.81 Mn |
| Sep 30, 2019 | -11.81 Mn |
| Jun 30, 2019 | -12.48 Mn |
| Jun 30, 2019 | -12.48 Mn |
| Mar 31, 2019 | -13.13 Mn |
| Mar 31, 2019 | -13.13 Mn |
| Dec 31, 2018 | 9.64 Mn |
| Dec 31, 2018 | 9.64 Mn |
| Sep 30, 2018 | -380,000.00 |
| Sep 30, 2018 | -380,000.00 |
| Jun 30, 2018 | -795,000.00 |
| Jun 30, 2018 | -795,000.00 |
| Mar 31, 2018 | -2.83 Mn |
| Mar 31, 2018 | -2.83 Mn |
| Dec 31, 2017 | 5.83 Mn |
| Dec 31, 2017 | 5.83 Mn |
| Sep 30, 2017 | -3.82 Mn |
| Sep 30, 2017 | -3.82 Mn |
| Jun 30, 2017 | -5.32 Mn |
| Jun 30, 2017 | -5.32 Mn |
| Mar 31, 2017 | -5.89 Mn |
| Mar 31, 2017 | -5.89 Mn |
| Dec 31, 2016 | 5.05 Mn |
| Dec 31, 2016 | 5.05 Mn |
| Sep 30, 2016 | -4.16 Mn |
| Sep 30, 2016 | -4.16 Mn |
| Jun 30, 2016 | -5.05 Mn |
| Jun 30, 2016 | -5.05 Mn |
| Mar 31, 2016 | -10.54 Mn |
| Mar 31, 2016 | -10.54 Mn |
| Dec 31, 2015 | 1.80 Mn |
| Dec 31, 2015 | 1.80 Mn |
| Sep 30, 2015 | -2.94 Mn |
| Sep 30, 2015 | -2.94 Mn |
| Jun 30, 2015 | -5.89 Mn |
| Jun 30, 2015 | -5.89 Mn |
| Mar 31, 2015 | -8.83 Mn |
| Mar 31, 2015 | -8.83 Mn |
| Dec 31, 2014 | 1.65 Mn |
| Dec 31, 2014 | 1.65 Mn |
| Sep 30, 2014 | -2.45 Mn |
| Sep 30, 2014 | -2.45 Mn |
| Jun 30, 2014 | -1.07 Mn |
| Jun 30, 2014 | -1.07 Mn |
| Mar 31, 2014 | -9.84 Mn |
| Mar 31, 2014 | -9.84 Mn |
| Dec 31, 2013 | 1.43 Mn |
| Dec 31, 2013 | 1.43 Mn |
| Sep 30, 2013 | -1.06 Mn |
| Sep 30, 2013 | -1.06 Mn |
| Dec 31, 2012 | 2.78 Mn |
| Dec 31, 2012 | 2.78 Mn |
| Sep 30, 2012 | 4.91 Mn |
| Sep 30, 2012 | 4.91 Mn |
| Jun 30, 2012 | 4.93 Mn |
| Jun 30, 2012 | 4.93 Mn |
| Dec 31, 2011 | 3.72 Mn |
| Dec 31, 2011 | 3.72 Mn |